Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Safety Trial of Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer

NCT02548169 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT02548169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02548169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Safety Trial of Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer
Lead sponsor
Baylor Research Institute
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2015
Completion date
April 24, 2017
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer